Skip to main content
. 2022 Jun 2;13:883483. doi: 10.3389/fphar.2022.883483

TABLE 2.

Adverse drug reactions.

Adverse drug reactions (ADRs) Definition
Allergic skin reaction Any skin change characterized by pruritis, rash, acne, or photosensitivity reported by the patients and cross-examined by the physician for possible anti-TB drugs effects
Anemia At least 1 serum hemoglobin value <13 g/dl (male) or <11.5 g/dl (female)*
Arthralgia Joint pain reported by the patients and recorded by the physician with or without arthritis
Body pain and headache As reported by the patients
Dyspnoea Any difficulty in breathing as reported by the patients and evaluated by the physician
Gastrointestinal disturbances Any case of gastritis, nausea, vomiting, abdominal pain, or diarrhea reported by the patients or documented by the physician
Gynecomastia Consistent and painful enlargement of breast documented by the physician for possible anti-TB drug effects
Hemoptysis Spitting of blood with cough as reported by the patients and documented by the physician
Hepatotoxicity In the absence of symptoms, at least 1 elevated serum value of transaminase or bilirubin five times higher than the upper normal value or three times higher in case of symptoms
Hypothyroidism At least 1 increased serum TSH value >10 IU/ml*
Hypokalemia 1 serum potassium value <3 mmol/L*
Hyperuricemia At least 1 serum increased value of uric acid >9 mg/dl*
Nephrotoxicity At least 1 serum creatinine value >130 μmol/L*
Ototoxicity Hearing loss or tinnitus as reported by the patients and confirmed by audiometry or clinician examination
Peripheral neuropathy Symptoms linked with numbness or burning sensation of extremities as reported by the patients and evaluated by the physician
Psychiatric disturbances Any cases of depression or psychosis evaluated by a psychologist or psychiatrist
Sleep disturbances As reported by the patients and documented by the physician
Swelling Evaluated by the physician by physical examination
Vertigo and dizziness As reported by the patients and evaluated by the physician
Visual disturbances DIFFICULTY in vision as reported by the patients

Normal Ranges: Alanine aminotransferases (ALT) = up to 41 U/L; Bilirubin total = Up to 1.2 mg/dl; serum creatinine = 0.74–1.35 mg/dl; Hemoglobin (Hb) Male (13–18) g/dl Female (11.5–16.5) g/dl.